Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SU5416 with Neoadjuvant Chemoradiation for High-Risk Soft Tissue Sarcoma
NCT00023738Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Aug 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of semaxanib in soft tissue sarcoma (STS), sponsored by NRG Oncology. Started Aug 2001; status: completed.
02
Drugs
semaxanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00023738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023738.